Bioceres Crop Solutions Corp. (BIOX)
NASDAQ: BIOX · IEX Real-Time Price · USD
12.09
+0.01 (0.04%)
Apr 26, 2024, 10:43 AM EDT - Market open
Bioceres Crop Solutions Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for BIOX stock have an average target of 23, with a low estimate of 21 and a high estimate of 25. The average target predicts an increase of 90.32% from the current stock price of 12.09.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 9, 2024.
Analyst Ratings
The average analyst rating for BIOX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Roth MKM | Roth MKM | Strong Buy Maintains $20 → $21 | Strong Buy | Maintains | $20 → $21 | +73.77% | Feb 9, 2024 |
Roth MKM | Roth MKM | Strong Buy Maintains $31 → $20 | Strong Buy | Maintains | $31 → $20 | +65.49% | Nov 1, 2023 |
Lake Street | Lake Street | Strong Buy Maintains $30 → $25 | Strong Buy | Maintains | $30 → $25 | +106.87% | Sep 12, 2023 |
Roth MKM | Roth MKM | Strong Buy Reiterates $31 | Strong Buy | Reiterates | $31 | +156.52% | Sep 12, 2023 |
Roth MKM | Roth MKM | Strong Buy Reiterates $31 | Strong Buy | Reiterates | $31 | +156.52% | Aug 16, 2023 |
Financial Forecast
Revenue This Year
502.25M
from 415.71M
Increased by 20.82%
Revenue Next Year
610.30M
from 502.25M
Increased by 21.51%
EPS This Year
0.44
from 0.30
Increased by 48.82%
EPS Next Year
1.17
from 0.44
Increased by 164.62%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 531.6M | 665.4M | 820.2M | 976.6M | 1.1B |
Avg | 502.3M | 610.3M | 796.7M | 948.7M | 1.1B |
Low | 473.1M | 558.6M | 765.5M | 911.5M | 1.0B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 27.9% | 32.5% | 34.4% | 22.6% | 17.0% |
Avg | 20.8% | 21.5% | 30.5% | 19.1% | 13.6% |
Low | 13.8% | 11.2% | 25.4% | 14.4% | 9.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 0.53 | 1.37 | 1.83 | 2.26 | 2.55 |
Avg | 0.44 | 1.17 | 1.77 | 2.19 | 2.48 |
Low | 0.33 | 0.88 | 1.71 | 2.11 | 2.38 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 76.8% | 208.8% | 56.2% | 27.2% | 16.3% |
Avg | 48.8% | 164.6% | 51.7% | 23.6% | 13.0% |
Low | 12.2% | 99.5% | 45.8% | 18.7% | 8.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.